Fluidigm Corp. closed its underwritten public offering of 9,372,500 common shares at $6.75 apiece for gross proceeds of about $63.3 million.
The shares sold include the full exercise of the underwriters' option to buy up to 1,222,500 additional shares.
Net proceeds from the offering were approximately $59.1 million after deducting underwriting discounts and commissions and the estimated expenses of the offering.
The South San Francisco, Calif.-based mass cytometry and microfluidics technologies company intends to use the net proceeds for general corporate purposes, including working capital, capital expenditures and continued research and development with respect to products and technologies, and to fund possible investments in or acquisitions of complementary businesses, products or technologies.
Piper Jaffray and UBS Investment Bank acted as joint book-running managers for the offering, while BTIG and Janney Montgomery Scott acted as co-managers.